KRM Ayurveda IPO GMP & Subscription Status: Day 1 IPO Live Updates

The KRM Ayurveda IPO GMP is ₹12 as of 21st January 2026. It is a book-building issue IPO of ₹77.49 crores. This is an entirely fresh issue of 0.57 crore shares. The issue will be listed on NSE and SME on its tentative listing date, 29th January 2026. The face value of KRM Ayurveda IPO shares is ₹10 per share, and the IPO price band is ₹128 to ₹135 per share. Retail investors can bid for a minimum of 2 lots of 2,000 shares worth ₹2,70,000. Scroll down to check the KRM Ayurveda IPO GMP and subscription details.

KRM Ayurveda IPO GMP Grey Market Premium

As mentioned earlier, the KRM Ayurveda IPO GMP currently stands at ₹6.00 per share. Thus, the estimated listing price would be at ₹130.00. This indicates that the estimated listing gain in this IPO could be 4.84%. Explore the table for KRM Ayurveda IPO GMP updates.

Note: GMP details are subject to change based on market conditions and fluctuations. Check the live KRM Ayurveda IPO GMP status at Univest.

Click and Sign Up to Get Live Updates on KRM Ayurveda IPO GMP Status

KRM Ayurveda IPO Subscription Status

As of now, the KRM Ayurveda IPO has been subscribed to 0.78 times. Of these, 1.25 times are subscribed by retail investors, 0.72 times by non-institutional investors, and 0.00 times by QII (Qualified Institutional Investors).  

The healthy subscription status indicates that investors are expecting higher returns at the time of KRM Ayurveda’s IPO listing on 28th January 2026. KRM Ayurveda also has a positive outlook behind the fresh issue of 0.57 crore shares, which will raise around Rs 77.49 crores.

Note: GMP details are subject to change based on market conditions and fluctuations. Check the live KRM Ayurveda IPO Subscription status at Univest.

Click and Sign Up to Get Live Updates on KRM Ayurveda IPO Subscription Status

KRM Ayurveda IPO Details

Also Read: KRM Ayurveda IPO GMP & Review: Apply or Avoid?

Explanation

KRM Ayurveda IPO: KRM Ayurveda IPO Limited has declared an issue price band of ₹128 to ₹135 per share. With this IPO, the company allows retail investors to bid for at least 2 lots of 2,000 shares, each worth ₹2,70,000. The face value of KRM Ayurveda IPO Limited shares is ₹10 per share. The shares of KRM Ayurveda IPO Limited will be listed on NSE and SME on its tentative listing day, 29th January 2026. Scroll down to check GMP updates and KRM Ayurveda IPO reviews. 

About KRM Ayurveda Ltd.

KRM Ayurveda Limited was established on 3 September 2019. KRM Ayurveda Ltd. operates a network of hospitals and clinics across multiple cities in India and has also marked its presence abroad through telemedicine consulting and sales. They manufacture Ayurvedic products, herbal and botanical remedies, medicines, supplements and possibly skin care/wellness-related items. Presently, the company runs 6 (Six) Hospitals and 5 (Five) Clinics at different locations in the country. Hospitals and Clinics are equipped with the following infrastructure & facilities:

• Beds, including general wards and premium rooms.
• Panchakarma treatment units.
• Herbal pharmacy and medicine preparation unit.
• Ayurvedic diet kitchen
• Consultation chambers for Vaidyas (Ayurvedic physicians).
• In-house yoga and meditation hall.

KRM Ayurveda Limited Financials

The company’s financial analysis is essential before applying for the KRM Ayurveda IPO. Look at the table to learn about KRM Ayurveda Limited’s financials. 

Explanation

KRM Ayurveda Limited’s revenue increased by 13.88% from ₹67.57 crores in March 2024 to ₹76.95 crores in March 2025. Moreover, the company’s PAT increased by 254.83% from ₹3.41 crores in March 2024 to ₹12.10 crores in March 2025.

KRM Ayurveda IPO Objectives

The primary aim of the KRM Ayurveda IPO is to raise ₹77.49 crores. On the other hand, KRM Ayurveda has decided to utilise these funds in different ways.

• To Capital Expenditure for Construction and Development of Telemedicine Operational Facilities
• To purchase CRM Software and Hardware Infrastructure
• To General Corporate Expenses.
• To Human Resources
• To Repayment/Prepayment of loan
• To Working Capital Requirement

KRM Ayurveda IPO Registrar

Skyline Financial Services Private Limited is the registrar for the KRM Ayurveda IPO, awaiting the allotment process and initiating refunds. For any queries regarding the KRM Ayurveda allotment and refund, you can contact Skyline Financial Services Private Limited at 

ipo@skylinerta.com or at 02228511022.

Download the Univest iOS App or Univest Android App to get daily stock recommendations and insightful research pieces! 

KRM Ayurveda IPO Review

The KRM Ayurveda IPO has gained neutral ratings from industry experts, brokers, and institutional investors. KRM Ayurveda Limited’s revenue increased by 13.88% from ₹67.57 crores in March 2024 to ₹76.95 crores in March 2025. Moreover, the company’s PAT increased by 254.83% from ₹3.41 crores in March 2024 to ₹12.10 crores in March 2025.

Most analysts recommend applying for this IPO to diversify your investment portfolio. However, we’re waiting for additional ratings to get a clearer picture and will keep posting them to deliver real-time insights. Until then, you can explore the company’s technical analysis to know whether you should apply for the KRM Ayurveda IPO or not.

The P/E ratio of KRM Ayurveda Limited shares is 1732, and its Earnings Per Share (EPS) stands at 7.79. Thus, the KRM Ayurveda IPO can deliver gains on its tentative listing date, 27th January 2026. 

Note: The data, as mentioned above, is taken from authentic sources and highlights pre-issue information. The PE ratio and EPS of KRM Ayurveda Limited are subject to change after the IPO. Explore the table below to get post-issue updates on these two metrics. 

FAQs on KRM Ayurveda IPO

What is the KRM Ayurveda IPO GMP?

Currently, on 21st January 2026, the KRM Ayurveda IPO GMP (Grey Market Premium) stands at ₹12. This indicates that the estimated listing price could be ₹147.00 per share.

What is the issue price of the KRM Ayurveda IPO?

The KRM Ayurveda IPO issue price band is set at ₹128.00 to ₹135.00 per share. Retail investors can apply for a minimum of 1 lots, each consisting of 2,000 shares, worth ₹2,70,000. Moreover, HNIs are required to bid for a minimum of 3 lots (3,000 shares) worth ₹4,05,000.

Who is the registrar of the KRM Ayurveda IPO?

Skyline Financial Services Private Limited is the registrar for the KRM Ayurveda IPO, awaiting the allotment process and initiating refunds. For any queries regarding the KRM Ayurveda allotment and refund, you can contact Skyline Financial Services Private Limited at 

ipo@skylinerta.com or at 02228511022.

Disclaimer: The above information is compiled from authentic sources and is just for informational purposes. To have detailed information about the KRM Ayurveda IPO, download the KRM Ayurveda IPO RHP and KRM Ayurveda IPO DRHP. Conduct your research before investing in IPOs to avoid significant losses. You can also consult your financial advisor.

Recent Articles

Aritas Vinyl IPO GMP & Subscription Status: Day 2

Digilogic Systems IPO

KRM Ayurveda IPO

Defrail Technologies IPO Listing Today

Bharat Coking Coal IPO Listing Today